DCF
Free cash flow, growth, discount rate, and terminal growth form an intrinsic value range.
-
US · US
FSLR.US latest organized financial period shows revenue grew +24.09% YoY and net income grew +18.28% YoY. Current price is about 191 USD, while the model base case is about 277 USD; the current price sits -31.3% versus the base case. The page shows both reported and adjusted views; valuation still defaults to reported figures, while adjusted figures help isolate structured one-time-item impact. This summary is intended for public-information research and model review.
Annual financial metrics with switchable views. · Unit: USD
Price date: 2026/04/29 · Updated: 2026/04/29 15:28
Hover each model row to inspect formulas and inputs.
-31.32%
Free cash flow, growth, discount rate, and terminal growth form an intrinsic value range.
-
Uses recent net income as an owner-earnings proxy and discounts scenario growth.
-57.67%
Solves the forward FCF growth rate implied by the current price.
Current price implies roughly 3.1% annualized FCF growth.
Estimates earnings power value without assuming growth.
+82.02%
Updated: 2026/04/29 15:28
Collapsed by default. Expand to inspect structured one-time items and adjusted figures without making them the primary page focus.
A positive amountAfterTax means the item increased reported net income; a negative value means it reduced reported net income. Adjusted net income = reported net income minus total after-tax impact. Valuation defaults to reported figures; adjusted figures are shown to observe one-time-item impact.
| Period | Item | Category | After-tax impact | Confidence |
|---|---|---|---|---|
| 2024/12/31 | Asset impairment | Impairment | -1M USD | Medium |
| 2024/12/31 | Business sale gain/loss | Asset sale gain/loss | 2M USD | Medium |
| 2024/12/31 | Loss contingency | Litigation | -679K USD | Medium |
| 2023/12/31 | Asset impairment | Impairment | -2M USD | Medium |
| 2023/12/31 | Business sale gain/loss | Asset sale gain/loss | 16M USD | Medium |
| 2023/12/31 | Loss contingency | Litigation | -84M USD | Medium |
| 2022/12/31 | Asset impairment | Impairment | -150M USD | Medium |
| 2022/12/31 | Business sale gain/loss | Asset sale gain/loss | 601M USD | Medium |
| 2021/12/31 | Asset impairment | Impairment | -54M USD | Medium |
| 2021/12/31 | Business sale gain/loss | Asset sale gain/loss | 349M USD | Medium |
| 2020/12/31 | Asset impairment | Impairment | -85M USD | Medium |
| 2020/12/31 | Loss contingency | Litigation | -14M USD | Medium |
| 2024/09/30 | Business sale gain/loss | Asset sale gain/loss | 2M USD | Medium |
| 2024/09/30 | Loss contingency | Litigation | -679K USD | Medium |
| 2024/06/30 | Business sale gain/loss | Asset sale gain/loss | 2M USD | Medium |
| 2024/06/30 | Loss contingency | Litigation | -1M USD | Medium |
| 2024/03/31 | Business sale gain/loss | Asset sale gain/loss | 2M USD | Medium |
| Period | Type | Revenue | Net Income | Adjusted net income | Free Cash Flow | Diluted EPS | Adjusted EPS |
|---|---|---|---|---|---|---|---|
| 2025/12/31 | Annual | 5B USD | 2B USD | - | 1B USD | 14.21 | - |
| 2024/12/31 | Annual | 4B USD | 1B USD | 1B USD | -308M USD | 12.02 | 12.02 |
| 2023/12/31 | Annual | 3B USD | 831M USD | 901M USD | -785M USD | 7.74 | 8.4 |
| 2022/12/31 | Annual | 3B USD | -44M USD | -495M USD | -30M USD | -0.41 | -4.59 |
| 2021/12/31 | Annual | 3B USD | 469M USD | 174M USD | -303M USD | 4.38 | 1.62 |
Total revenue recognized in each fiscal year.
Adjusted close trend. Current price sample covers: 2025/04/16 - 2026/04/29.